Manufacturer
Shorla Oncology
- Products listed
- 4
- Molecules
- 3
- Therapy areas
- 1
Shorla Oncology is a pharmaceutical manufacturer based in an unrecorded country. MedsAcross lists 4 of its products across 3 molecules, each with registers, packs and availability for export supply to licensed buyers.
- Indian manufacturer
- No
- Also listed as
- Shorla Oncology INC., Shorla Oncology Inc., Shorla Oncology Inc.,
- US FDA labeler
- YesSource: openFDA NDC directory
Source from this manufacturer
We supply Shorla Oncology products through licensed channels, with the documents your regulator needs.
Oncology
4 presentations
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Imkeldi 80 mg/mL oral solutionOral | Imatinib | US FDA | Available on request |
| Jylamvo 2 mg/mL oral solutionOral | Methotrexate | US FDA | Available on request |
| Nelarabine 250 mg/50 mL injectionIntravenousGeneric name | Nelarabine | US FDA | Available on request |
| Nelarabine 375 mg/75 mL injectionIntravenousGeneric name | Nelarabine | US FDA | Available on request |
Molecules made
Manufacturer facts come from public registers and are shown with their source. Listing does not mean the manufacturer endorses MedsAcross.
Source from Shorla Oncology
Send a request for any of these products. We confirm the licensed source, documents and lead time.